Zobrazit minimální záznam

New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

dc.contributor.authorDřevínek, Pavel
dc.contributor.authorCanton, Rafael
dc.contributor.authorJohansen, Helle Krogh
dc.contributor.authorHoffman, Lucas
dc.contributor.authorCoenye, Tom
dc.contributor.authorBurgel, Pierre-Regis
dc.contributor.authorDavies, Jane C
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1651
dc.description.abstractIn this review, we summarize the main points that were raised and highlighted during the pre-conference meeting to the 17(th) European Cystic Fibrosis Society Basic Science Conference, held from 30 March to 2 April, 2022 in Albufeira, Portugal. Keynote lectures provided an update on the latest information regarding the phenomenon of antimicrobial resistance (AMR) in cystic fibrosis (CF). Traditional themes such as in vitro antibiotic susceptibility testing and its clinical value, AMR evolution in persistent Pseudomonas aeruginosa infection and the impact of biofilm on AMR were discussed. In addition, the report gives an overview on very recent AMR-related topics that include an ecological view of AMR in CF lung, referred to as resistome, and novel anti-infective approaches in preclinical or early clinical research such as antibiofilm drugs and bacteriophages.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1016/j.jcf.2022.10.005
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleNew concepts in antimicrobial resistance in cystic fibrosis respiratory infectionsen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2023-12-20T15:10:44Z
dc.subject.keywordAntimicrobial resistanceen
dc.subject.keywordAntimicrobial strategiesen
dc.subject.keywordAntimicrobial susceptibility testingen
dc.subject.keywordBiofilmen
dc.subject.keywordPathoadaptationen
dc.subject.keywordResistomeen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5103
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/FN/I-FN/I-FNM
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/COOP/COOP
dc.date.embargoStartDate2023-12-20
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1016/j.jcf.2022.10.005
dc.identifier.utWos000928202100007
dc.identifier.eidScopus2-s2.0-85140054898
dc.identifier.obd616655
dc.identifier.rivRIV/00216208:11130/22:10448996
dc.identifier.rivRIV/00064203:_____/22:10448996
dc.identifier.pubmed36270946
dc.subject.rivPrimary30000::30300::30303
dcterms.isPartOf.nameJournal of Cystic Fibrosis
dcterms.isPartOf.issn1569-1993
dcterms.isPartOf.journalYear2022
dcterms.isPartOf.journalVolume21
dcterms.isPartOf.journalIssue6
uk.faculty.primaryId109
uk.faculty.primaryName2. lékařská fakultacs
uk.faculty.primaryNameSecond Faculty of Medicineen
uk.faculty.secondaryId52
uk.faculty.secondaryNameFakultní nemocnice v Motolecs
uk.faculty.secondaryNameMotol University Hospitalen
uk.department.primaryId109
uk.department.primaryName2. lékařská fakultacs
uk.department.primaryNameSecond Faculty of Medicineen
uk.department.secondaryId1701
uk.department.secondaryId100010693902
uk.department.secondaryNameÚstav lékařské mikrobiologiecs
uk.department.secondaryNameÚstav lékařské mikrobiologieen
uk.department.secondaryNameÚstav lékařské mikrobiologie 2. LF UK a FN Motolcs
uk.department.secondaryNameDepartment of Medical Microbiology, 2nd Faculty of Medicine and Motol University Hospitalen
dc.description.pageRange937-945
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::přehledový článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::summarizing articleen
dc.type.obdHierarchyCode73::152::205en
uk.displayTitleNew concepts in antimicrobial resistance in cystic fibrosis respiratory infectionsen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam